● Share prices are approaching a strong support area in daily data, which offers good timing for investors.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the past twelve months, EPS forecast has been revised upwards.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● Based on current prices, the company has particularly high valuation levels.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.